Literature DB >> 8845689

A change in ocular involvement in a patient suffering from ankylosing spondylitis and Behçet's disease.

I Beiran1, J Scharf, D Dori, B Miller.   

Abstract

We report a case of a young man suffering from both ankylosing spondylitis and Behçet's disease in whom the character of the ocular involvement changed according to the predominant disease at a given time. When the clinical picture was one of ankylosing spondylitis, only anterior uveitis was observed, while the clinical picture of Behçet's disease occurred with panuveitis and retinal vasculitis. To the best of our knowledge, this is the first report in the English literature of two different patterns of ocular involvement in the same patient with two seronegative arthritides.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8845689     DOI: 10.1177/112067219500500309

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   1.922


  4 in total

Review 1.  Coexisting Behçet's disease and ankylosing spondylitis presented with deep venous thrombosis: a case report and review of the literature.

Authors:  Wan-Hee Yoo
Journal:  Rheumatol Int       Date:  2010-03-30       Impact factor: 2.631

2.  Successful treatment with adalimumab in a patient with coexisting Behçet's disease and ankylosing spondylitis.

Authors:  Necmettin Yildiz; Hakan Alkan; Fusun Ardic; Oya Topuz
Journal:  Rheumatol Int       Date:  2009-08-25       Impact factor: 2.631

3.  A case of coexisting Behçet's disease and ankylosing spondylitis.

Authors:  H K Chang; E H Cho; J U Kim; H Herr
Journal:  Korean J Intern Med       Date:  2000-01       Impact factor: 2.884

4.  Risk of immune-mediated inflammatory diseases in newly diagnosed ankylosing spondylitis patients: a population-based matched cohort study.

Authors:  Hsin-Hua Chen; Wen-Cheng Chao; Yi-Hsing Chen; Tsu-Yi Hsieh; Kuo-Lung Lai; Yi-Ming Chen; Wei-Ting Hung; Ching-Tsai Lin; Chih-Wei Tseng; Ching-Heng Lin
Journal:  Arthritis Res Ther       Date:  2019-08-29       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.